HomeASND • NASDAQ
add
Ascendis Pharma A/S
Previous close
$137.20
Day range
$133.53 - $138.36
Year range
$83.75 - $161.00
Market cap
7.73B USD
Avg Volume
299.18K
Primary exchange
NASDAQ
Top news
Financials
Income Statement
Revenue
Net income
(EUR) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 95.89M | 185.49% |
Operating expense | 137.47M | -20.38% |
Net income | -131.04M | -18.14% |
Net profit margin | -136.65 | 58.62% |
Earnings per share | -2.30 | -16.16% |
EBITDA | -44.67M | 67.90% |
Effective tax rate | -1.95% | — |
Balance Sheet
Total assets
Total liabilities
(EUR) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 320.24M | -45.33% |
Total assets | 802.50M | -16.95% |
Total liabilities | 1.04B | 30.24% |
Total equity | -238.18M | — |
Shares outstanding | 56.88M | — |
Price to book | -32.74 | — |
Return on assets | -15.09% | — |
Return on capital | -26.44% | — |
Cash Flow
Net change in cash
(EUR) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -131.04M | -18.14% |
Cash from operations | -101.58M | 30.92% |
Cash from investing | 7.16M | -96.60% |
Cash from financing | 18.42M | 2,724.36% |
Net change in cash | -71.92M | -227.27% |
Free cash flow | -124.91M | -42.30% |
About
Founded
2006
Website
Employees
879